CORM-401 |
| Catalog No.GC34893 |
CORM-401 contains manganese (Mn) as a metal center, CORM-401 can release CO.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1001015-18-4
Sample solution is provided at 25 µL, 10mM.
CORM-401 contains manganese (Mn) as a metal center, CORM-401 can release CO[1].
When 20 µM CORM-401 was added to a PBS solution containing 100 µM Mb, the formation of MbCO can be detected. By calculating the concentration of MbCO over time and by performing curve fitting, it was established that the half-lives of CO release were 14.1, 13.4 and 11.9 min for 5, 10 and 20 µM CORM-401, respectively. The amount of CO released from the compound diminishes as the ratio of CORM-401/Mb increases[2].
After exposure to 20 µM CORM-401 loaded EA.hy926 endothelial cells displayed increased levels of intracellular CO[2]. Upon CORM-401 exposure EROD activity of recombinant Cytochrome P450-dependent monooxygenases (CYP) decreased concentration dependently. Treatment with CORM-401 decreased EROD activity in HepG2 cells at concentrations higher than 50 µM CORM-401 [4]. CORM-401 partially reduced TNF-α/CHX-induced total cellular ROS,and reduced the effect of antimycin-A[5]. CORM-401 (10-100µM) induced a persistent increase in the oxygen consumption rate (OCR) that was accompanied by inhibition of glycolysis (extracellular acidification rate, ECAR) and a decrease in ATP-turnover. Furthermore, CORM-401 increased proton leak, diminished mitochondrial reserve capacity and enhanced non-mitochondrial respiration[6]. CORM-401 caused an apparent suppression of NO production through inhibition of iNOS at both the mRNA and protein levels in RAW264.7 cells stimulated with P. intermedia LPS. CORM-401 upregulated the expression of both the HO-1 gene and its protein in LPS-activated cells, and treatment with the HO-1 inhibitor significantly reversed the attenuating influence of CORM-401 against LPS-induced generation of NO[7].
Oral administration of CORM-401 reduces body weight gain and improves insulin resistance in HFD-induced obesity in mice.The transient uncoupling activity of CO elicited by repetitive administration of CORM-401 is associated with lower weight gain and increased insulin sensitivity during HFD[3].
References:
[1]. Crook SH, Mann BE, et,al. [Mn(CO)4{S2CNMe(CH2CO2H)}], a new water-soluble CO-releasing molecule. Dalton Trans. 2011 Apr 28;40(16):4230-5. doi: 10.1039/c1dt10125k. Epub 2011 Mar 14. PMID: 21403944.
[2]. Fayad-Kobeissi S, Ratovonantenaina J, et,al.Vascular and angiogenic activities of CORM-401, an oxidant-sensitive CO-releasing molecule. Biochem Pharmacol. 2016 Feb 15;102:64-77. doi: 10.1016/j.bcp.2015.12.014. Epub 2015 Dec 22. PMID: 26721585.
[3]. Braud L, Pini M, et,al.Carbon monoxide-induced metabolic switch in adipocytes improves insulin resistance in obese mice. JCI Insight. 2018 Nov 15;3(22):e123485. doi: 10.1172/jci.insight.123485. PMID: 30429365; PMCID: PMC6302946.
[4]. Walter M, Stahl W, et,al. Carbon monoxide releasing molecule 401 (CORM-401) modulates phase I metabolism of xenobiotics. Toxicol In Vitro. 2019 Sep;59:215-220. doi: 10.1016/j.tiv.2019.04.018. Epub 2019 Apr 17. PMID: 31004742.
[5]. Babu D, Leclercq G, et,al.Differential Effects of CORM-2 and CORM-401 in Murine Intestinal Epithelial MODE-K Cells under Oxidative Stress. Front Pharmacol. 2017 Feb 8;8:31. doi: 10.3389/fphar.2017.00031. PMID: 28228725; PMCID: PMC5296622.
[6]. Kaczara P, Motterlini R, et,al.Carbon monoxide released by CORM-401 uncouples mitochondrial respiration and inhibits glycolysis in endothelial cells: A role for mitoBKCa channels. Biochim Biophys Acta. 2015 Oct;1847(10):1297-309. doi: 10.1016/j.bbabio.2015.07.004. Epub 2015 Jul 14. PMID: 26185029.
[7]. Choi EY, Lee JE, et,al. Carbon monoxide-releasing molecule-401, a water-soluble manganese-based metal carbonyl, suppresses Prevotella intermedia lipopolysaccharide-induced production of nitric oxide in murine macrophages. Immunopharmacol Immunotoxicol. 2022 Sep 8:1-8. doi: 10.1080/08923973.2022.2119998. Epub ahead of print. PMID: 36053007.
| Quantification of CO release using a myoglobin assay [1]: | |
Preparation method | 1 mL horse heart myoglobin solution prepared in phosphate buffered saline at the desired final concentration was transferred to a cuvette and converted to deoxymyoglobin (deoxyMb) by addition of granular sodium dithionite. A deoxyMb spectrum (500 600 nm) was recorded and then a 2-fold excess of CORM-3 was added to the cuvette to obtain a maximum carbonmonoxy-myoglobin (MbCO) spectrum (saturated MbCO). In a separate cuvette, the release of CO from CORM-401 was then measured by adding the compound to the deoxyMb solution overlaid with olive oil to prevent loss of CO or diffusion of atmospheric oxygen back into the solution. Samples were scanned immediately after addition of the compounds and at consecutive time-points to monitor the formation of MbCO. Experiments were conducted either by: (1) using CORM-401 at a final concentration of 10 μM and varying the concentration of myoglobin (25, 50 and 100 μM) or (2) testing the release of CORM-401 at 5, 10 or 20 μM after addition to a fixed concentration of myoglobin (100 μM). |
Applications | CO released by CORM-401 increases with the amount of Mb used in the assay. |
| Cell experiment [1]: | |
Cell lines | EA.hy926 endothelial cells |
Preparation Method | To assess the amount of CO delivered by CO-RMs intracellularly, EA.hy926 endothelial cells in DPBS (+Ca2+, +Mg2+) were treated with 20 μM CORM-401 or iCORM-401, CORM-3 or CORM-A1 for 15 min at 37 °C followed by 30 min incubation with 1 μM COP-1. The intracellular fluorescence, indicative of CO accumulation in cells, was quantified using a CyAn ADP LX7 Analyzer. |
Reaction Conditions | 20 μM CORM-401 for 15 min at 37 °C |
Applications | COP-1 loaded EA.hy926 endothelial cells displayed increased levels of intracellular CO after exposure to 20 μM CORM-401. |
| Animal experiment [2]: | |
Animal models | Eight-week-old male C57BL6 mice weighing approximately 25 g |
Preparation Method | Determined the levels of blood carbonmonoxy hemoglobin (COHb) in mice receiving CORM-401 at 2 different doses after oral gavage. |
Dosage form | CORM-401 15 mg/kg and 30 mg/kg, given orally 3 times a week. |
Applications | Oral administration of CORM-401 reduces body weight gain and improves insulin resistance in HFD-induced obesity in mice. |
References: | |
| Cas No. | 1001015-18-4 | SDF | |
| Canonical SMILES | O#C[Mn+]1(C#O)(C#O)([SH-]C(N(C)CC([O-])=O)=S1)C#O.[H+] | ||
| Formula | C8H8MnNO6S2 | M.Wt | 331.2 |
| Solubility | DMSO : 25 mg/mL (Need ultrasonic) | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.0193 mL | 15.0966 mL | 30.1932 mL |
| 5 mM | 0.6039 mL | 3.0193 mL | 6.0386 mL |
| 10 mM | 0.3019 mL | 1.5097 mL | 3.0193 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 32 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *